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1. Introduction
The science of nuclear medicine (NM) involves the administration of trace quantities of radio-
nuclide’s that are used to provide diagnostic information in a diverse range of diseases. In its 
most basic form, a NM study comprises of injecting a radiopharmaceutical, a combination of 
specific pharmaceutical tagged with a gamma-ray-emitting radioactive tracer into the body. 
There are a number of pharmaceutical available which are used for specific organ imaging. It 
function is to carry gamma emitting radioisotope into a specific organ. When the radionuclide 
decays, gamma rays photons are emitted. The energy of these gamma photons is such that 
a large number of photons are exited from the body without being scattered or attenuated. 
These photons are later detected by a position-sensitive instruments called gamma camera 
or scintillation camera and form an image of the distribution of the radionuclide, and hence 
the compound to which it was attached. There are two classes of nuclear medicine imag-
ing: single photon emission tomography which is essentially a single photon imaging and 
positron imaging. Single photon imaging usually comprises of either taking a planar image 
or a series of planar images around the body. A planar image is picture of radionuclide dis-
tribution in the patient from one angle. This results in an image having insufficient depth 
information, but which can still be diagnostically useful. In order to get depth information, 
data from various views are collected around the patient. This allows cross-sectional images 
of the distribution of the radionuclide which was later reconstructed employing specialized 
soft ware’s (these software’s use highly sophisticated algorithms), thus providing the depth 
information missing from planar imaging. Positron imaging uses radionuclide that decay by 
positron emission. The emitted positron usually has a very short lifetime and produces two 
high-energy photons after interacting with its counterpart electron. The two simultaneously 
emitted gamma photons having energies of 511 KeV subsequently are detected by an imaging 
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Material Density Atomic 
number (Z)
μ@511 keV (1/cm) (mean 
free path-mm)
Photo 
fraction (%)
Light output 
(photon/MeV)
Decaytime 
(ns)
λ 
(nm)
Energy resolution 
(%FWHM)
Hygroscopic Index of 
ref
BGO 7.1 75 0.95 (10.5) 40 9000 300 480 12 N 2.15
GSO 6.7 59 0.70 (14.1) 25 8000 60 440 9 N 1.85
LSO 7.4 66 0.88 (11.4) 32 30,000 40 420 10 N 1.82
NaI (TT) 3.7 51 0.34 (29.1) 17 41,000 230 410 8 Y 1.85
Table 1. Physical properties of PET scintillators.
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camera. Once again, topographic images are formed by collecting information from different 
angles around the patient, resulting in PET images; however detectors remain stationary and 
do not move around the patient as it happens in SPECT study. A list of physical properties of 
different types of scintillator used in nuclear medicine is described in Table 1. It is clear from 
the table the GSO and LSO are quite fast materials with the decay time of 60 ns and 40 ns and 
are most suitable for PET time of flight measurements. However, NaI (Tl) detectors are more 
sensitive and give strong output per unit absorption of energy.
Although the amount of radioactive tracers injected into the patient is very small, however, 
smaller quantities carry risk and therefore assessment of absorbed dose to the organs and 
whole body become essential. Considerable work has been done internationally so far on the 
assessment of dose to remnant thyroid tissue and whole body. A high level of radioactivity 
is usually prescribed in routine to ablate thyroid tissue, therefore, its accurate quantification 
as well as safety of radiation technologists is a must. Different methods of measuring activity 
while in shielding were proposed to reduce the extra radiation burden to allied radiation 
staff. Before giving therapeutic radioiodine, uptake in the thyroid tissue is determined using 
uptake system that provides an estimation of the remnant thyroid mass. The uptake value is 
a value that can be reproduced with great accuracy and same will also be made sure that the 
uptake value is reproducible. Currently the clinical practice of administering radioactivity to 
treat Differentiated Thyroid Cancer (DTC) varies widely from hospital to hospital and ranges 
from 1110 to 3700 MBq or even more. This increase in activity although does not confer any 
therapeutic benefits to the patients. The corresponding absorbed dose to thyroid mass also 
varies widely from (13–1161) Gy depending on the mass of the remnant thyroid tissue, dose 
rate and the absorbed cumulated activity. The whole body receives, in this case, an absorbed 
dose of 0.12–0.23 Gy. Since the radioiodine is a non-specific agent, it also deposits in other 
parts of the body giving unnecessary radiation dose for example breast, liver, etc. This is 
particular of important for lactating women. The empirically determined activity without any 
apparent correlation between absorbed dose and activity depends solely on the experience of 
the individual groups and can varies by an order of magnitude from the standard practice. 
High success of non-scientific approach was reported, however, 15% of patients with high-risk 
DTC have significantly reduced life expectancy even after getting treatment using conven-
tional approach of fixed amount of administered activity. The fixed-activity approach without 
assessing pretherapeutic lesion absorbed dose and toxicity assessment generally results in 
administration of low amount of therapeutic radiodine as compared to with absorbed dose 
assessment. In this era of personalized and precision medicine, individualized approach to 
treatment will bring more patient benefits and improve life expectancy. The quantity of activ-
ity should be given to patient that is right and as high as safely achievable (AHASA) [1–5].
2. Conclusions
Diagnostic reference levels (DRLs) and achievable doses (ADs), a form of investigation 
levels, represent an important tool in medical imaging as optimizing the radiation dose 
delivered to patients. It is essential to ensure that the appropriate clinical information is 
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available in the image throughout the optimization process. In order to implement optimi-
zation process, both patient dose and clinical utility must be taken into account depending 
on image quality.
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Abbreviations
NM nuclear medicine
SPECT single photon emission computed tomography
GSO gadolinum orthosilicate
LSO lutetium orthosilicate
PET positron emission tomography
NaI(Tl) sodium iodide thallium activated
MBq mega becqural
DTC differentiated thyroid cancer
Gy gray
AHASA as high as safely achievable
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